Why the study?
Does recent antipsychotic exposure increase the risk of acute myocardial infarction in patients with serious mental illness?
Does recent antipsychotic exposure increase the risk of acute myocardial infarction in patients with serious mental illness?
Recent antipsychotic exposure is associated with a short-term increased risk of acute myocardial infarction in patients with schizophrenia, particularly in men and those without prior cardiovascular risk factors.
Recent antipsychotic exposure was associated with AMI in schizophrenia but not bipolar disorder; hypothesis-generating and requires prospective confirmation before practice change.
OBJECTIVE: To investigate the association between acute myocardial infarction (AMI) and recent exposure to antipsychotic agents in people with serious mental illness (SMI), and modifying influences. METHOD: A case-crossover design was applied using the Taiwan National Health Insurance Research Database (NHIRD) to compare the exposure frequency of antipsychotic agents within individuals of schizophrenia or bipolar disorder between 60-day case and control periods prior to their first AMI episode during 1996-2007. RESULTS: A sample of 834 patients with incident AMI was analysed. AMI was significantly associated with more recent antipsychotic exposure in schizophrenia after adjustment (OR 1.87, 95% confidence interval 1.15-3.03) bipolar disorder (OR 1.06, 0.51-2.21). This association in schizophrenia was significantly stronger in men and in patients without previous diagnoses of cardiovascular risk factors. CONCLUSION: These findings are consistent with a short-term risk effect of antipsychotic exposure on risk of AMI and identify potentially vulnerable groups. Further research is required to clarify underlying biological mechanisms.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: